[ad_1]
Astra Zeneca, who continued to be recruited by the University of Oxford, it was justified that after a participant’s discomfort in clinical trials, the routine procedure was applied and trials with mothers were discontinued.
The month was cleared from AstraZeneca, a company that had been recruiting at the University of Oxford. The company has stated that it is discontinuing trials with mothers, which are in the final stages of clinical trials.
Quoting company officials from American Stat News, a participant in clinical trials in the UK showed serious adverse effects. In addition to that, the company suspended the lawsuits of mothers.
“THE RUTN PROCEDURE IS APPLIED, THE SOURCE IS WAITING”
The AstraZeneca company made a statement via email about the situation.
In clarification, attention was drawn to the fact that the trials were stopped due to a discomfort that was seen in the days and the source was not determined, and this was a routine process.
In the New York Times report; He wrote that a British participant had ‘transverse myelitis’, an inflammatory disease that affects the spinal cord and is usually caused by viral infections. AstraZeneca officials did not comment on the report.
You can rate this news 0 0
[ad_2]
